Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J H Shih

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Cancer Research and Cellular Therapeutics|June 25, 2020
The Tale of CHD4 in DNA Damage Response and Chemotherapeutic ResponseJing Zhang, David J H Shih, Shiaw-Yih Lin
Biomarker Research|July 3, 2020
Role of DNA repair defects in predicting immunotherapy responseJing Zhang, David J H Shih, Shiaw-Yih Lin
Journal of the National Cancer Center|July 22, 2024
Tumour mutational burden is overestimated by target cancer gene panelsHu Fang, Johanna Bertl, Xiaoqiang Zhu, et al.
Bioinformatics (Oxford, England)|February 17, 2022
CNGPLD: case-control copy-number analysis using Gaussian process latent differenceDavid J H Shih, Ruoxing Li, Peter Müller, et al.
International Journal of Molecular Sciences|June 2, 2021
A Gene Expression Signature to Predict Nucleotide Excision Repair Defects and Novel Therapeutic ApproachesRongbin Wei, Hui Dai, Jing Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health recordsZhao Li, Lan Lan, Yujia Zhou, et al.
Journal of Biomedical Informatics|March 23, 2024
Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health recordsZhao Li, Lan Lan, Yujia Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
GPCRs in CAR-T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic EfficacyZhuoqun Liu, Yuchen Xiao, Yamin Zhao, et al.
NPJ Vaccines|April 1, 2024
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccineXiaohua Ye, David J H Shih, Zhiqiang Ku, et al.
American Journal of Cancer Research|February 10, 2022
Exploiting induced vulnerability to overcome PARPi resistance and clonal heterogeneity in BRCA mutant triple-negative inflammatory breast cancerDavid J H Shih, Mei-Kuang Chen, Jun Yin, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Cancer Research and Cellular Therapeutics|June 25, 2020
The Tale of CHD4 in DNA Damage Response and Chemotherapeutic ResponseJing Zhang, David J H Shih, Shiaw-Yih Lin
Biomarker Research|July 3, 2020
Role of DNA repair defects in predicting immunotherapy responseJing Zhang, David J H Shih, Shiaw-Yih Lin
Journal of the National Cancer Center|July 22, 2024
Tumour mutational burden is overestimated by target cancer gene panelsHu Fang, Johanna Bertl, Xiaoqiang Zhu, et al.
Bioinformatics (Oxford, England)|February 17, 2022
CNGPLD: case-control copy-number analysis using Gaussian process latent differenceDavid J H Shih, Ruoxing Li, Peter Müller, et al.
International Journal of Molecular Sciences|June 2, 2021
A Gene Expression Signature to Predict Nucleotide Excision Repair Defects and Novel Therapeutic ApproachesRongbin Wei, Hui Dai, Jing Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health recordsZhao Li, Lan Lan, Yujia Zhou, et al.
Journal of Biomedical Informatics|March 23, 2024
Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health recordsZhao Li, Lan Lan, Yujia Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
GPCRs in CAR-T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic EfficacyZhuoqun Liu, Yuchen Xiao, Yamin Zhao, et al.
NPJ Vaccines|April 1, 2024
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccineXiaohua Ye, David J H Shih, Zhiqiang Ku, et al.
American Journal of Cancer Research|February 10, 2022
Exploiting induced vulnerability to overcome PARPi resistance and clonal heterogeneity in BRCA mutant triple-negative inflammatory breast cancerDavid J H Shih, Mei-Kuang Chen, Jun Yin, et al.
Pageof 4